H. Kolesnikov-Gauthier

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by ¹⁸F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

Pierre Véra, S. Thureau, Philippe Chaumet‐Riffaud et al. · Journal of Nuclear Medicine · 2017 · 81 citations · Full text

Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG–PET after the first course

H. Kolesnikov-Gauthier, Laurence Vanlemmens, Marie‐Christine Baranzelli et al. · Breast Cancer Research and Treatment · 2011 · 51 citations

Breast Oncology, Radiology, Medicine +7

Interobserver Agreement of Qualitative Analysis and Tumor Delineation of ¹⁸F-Fluoromisonidazole and 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET Images in Lung Cancer

S. Thureau, Philippe Chaumet‐Riffaud, Romain Modzelewski et al. · Journal of Nuclear Medicine · 2013 · 48 citations · Full text

FDG PET in patients with cancer of an unknown primary

H. Kolesnikov-Gauthier, Éric Levy, Pascal Merlet et al. · Nuclear Medicine Communications · 2005 · 40 citations

Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer.

H. Kolesnikov-Gauthier, Philippe Carpentier, Pascal Depreux et al. · PubMed · 2000 · 40 citations